Evidence map›Paper›PMID 20211135›Full record

ArticleCell2010

miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.

Anna M Eiring, Jason G Harb, Paolo Neviani, Christopher Garton, Joshua J Oaks, Riccardo Spizzo, Shujun Liu, Sebastian Schwind, Ramasamy Santhanam, Christopher J Hickey and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 285 papers.

0numbers the graph read from it
0cells of the map it votes in
285citing papers in PubMed
24.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

285 citing papers in PubMed, 562 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Plant pathogenic nematode exosomes remodel vector tracheae to enhance pathogen transmission.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. MicroRNA Gets a Mighty Award.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  15. Review
  16. Article
  17. Article
  18. MicroRNAs in diabetic macroangiopathy.Cardiovascular diabetology · 2024
    Review
  19. Article
  20. Article

225 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 3 countries.

Anna M EiringHuman Cancer Genetics Program, Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA.
Jason G Harb
Paolo Neviani
Christopher Garton
Joshua J Oaks
Riccardo Spizzo
Shujun Liu
Sebastian Schwind
Ramasamy Santhanam
Christopher J Hickey
Heiko Becker
Jason C Chandler
Raul Andino
Jorge Cortes
Peter Hokland
Claudia S Huettner
Ravi Bhatia
Denis C Roy
Stephen A Liebhaber
Michael A Caligiuri
Guido Marcucci
Ramiro Garzon
Carlo M Croce
George A Calin
Danilo Perrotti
The Ohio State University · USCancer Genetics (United States) · USThe University of Texas MD Anderson Cancer Center · USAarhus University · DKCity Of Hope National Medical Center · USDana-Farber Cancer Institute · USHôpital Maisonneuve-Rosemont · CAUniversity of California, San Francisco · USUniversity of Pennsylvania · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Role of RNA-Binding Proteins in BCR/ABL LeukemogenesisR01CA095512 · NCI · OHIO STATE UNIVERSITY · PI PERROTTI, DANILO · 2003 to 2012
$2.2M
NCI NIH HHS CA095512NCI NIH HHS CA16058NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA095512
6 · The paper itself

Abstract

MicroRNAs and heterogeneous ribonucleoproteins (hnRNPs) are posttranscriptional gene regulators that bind mRNA in a sequence-specific manner. Here, we report that loss of miR-328 occurs in blast crisis chronic myelogenous leukemia (CML-BC) in a BCR/ABL dose- and kinase-dependent manner through the MAPK-hnRNP E2 pathway. Restoration of miR-328 expression rescues differentiation and impairs survival of leukemic blasts by simultaneously interacting with the translational regulator poly(rC)-binding protein hnRNP E2 and with the mRNA encoding the survival factor PIM1, respectively. The interaction with hnRNP E2 is independent of the microRNA's seed sequence and it leads to release of CEBPA mRNA from hnRNP E2-mediated translational inhibition. Altogether, these data reveal the dual ability of a microRNA to control cell fate both through base pairing with mRNA targets and through a decoy activity that interferes with the function of regulatory proteins.

Indexed as

AnimalsBlast CrisisCCAAT-Enhancer-Binding ProteinsCell Line, TumorHeterogeneous-Nuclear RibonucleoproteinsHumansLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMiceMicroRNAsProto-Oncogene Proteins c-pim-1RNA-Induced Silencing ComplexCCAAT-Enhancer-Binding ProteinsCEBPA protein, humanHeterogeneous-Nuclear RibonucleoproteinsMicroRNAsMIRN328 microRNA, humanMIRN328 microRNA, mousePIM1 protein, humanProto-Oncogene Proteins c-pim-1RNA-Induced Silencing Complex

Identifiers

PMID20211135
PMCPMC2924756
OpenAlexW2094097897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.